| Novel Tacrine‐Grafted Ugi Adducts as Multipotent Anti‐Alzheimer Drugs: A Synthetic Renewal in Tacrine–Ferulic Acid Hybrids M Benchekroun, M Bartolini, J Egea, A Romero, E Soriano, M Pudlo, ... ChemMedChem 10 (3), 523-539, 2015 | 81 | 2015 |
| New cinnamic–N-benzylpiperidine and cinnamic–N, N-dibenzyl (N-methyl) amine hybrids as Alzheimer-directed multitarget drugs with antioxidant, cholinergic, neuroprotective and … M Estrada, C Herrera-Arozamena, C Pérez, D Viña, A Romero, ... European journal of medicinal chemistry 121, 376-386, 2016 | 61 | 2016 |
| Novel N-Acetyl Bioisosteres of Melatonin: Melatonergic Receptor Pharmacology, Physicochemical Studies, and Phenotypic Assessment of Their Neurogenic … M de la Fuente Revenga, N Fernandez-Saez, C Herrera-Arozamena, ... Journal of Medicinal Chemistry 58 (12), 4998-5014, 2015 | 45 | 2015 |
| Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease ME Valencia, C Herrera-Arozamena, L de Andrés, C Pérez, ... European journal of medicinal chemistry 156, 534-553, 2018 | 44 | 2018 |
| Recent advances in neurogenic small molecules as innovative treatments for neurodegenerative diseases C Herrera-Arozamena, O Martí-Marí, M Estrada, M De la Fuente Revenga, ... Molecules 21 (9), 1165, 2016 | 38 | 2016 |
| New flavonoid – N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer´s disease endowed with neurogenic properties M Estrada-Valencia, C Herrera-Arozamena, C Pérez, D Viña, ... Journal of enzyme inhibition and medicinal chemistry 34 (1), 712-727, 2019 | 27 | 2019 |
| Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties C Herrera-Arozamena, M Estrada-Valencia, C Pérez, L Lagartera, ... European Journal of Medicinal Chemistry 190, 112090, 2020 | 17 | 2020 |
| New coumarin-based fluorescent melatonin ligands. Design, synthesis and pharmacological characterization M De La Fuente Revenga, C Herrera-Arozamena, N Fernández-Sáez, ... European journal of medicinal chemistry 103, 370-373, 2015 | 17 | 2015 |
| Resveratrol-based MTDLs to stimulate defensive and regenerative pathways and block early events in neurodegenerative cascades C Herrera-Arozamena, M Estrada-Valencia, P López-Caballero, C Pérez, ... Journal of Medicinal Chemistry 65 (6), 4727-4751, 2022 | 10 | 2022 |
| Optimization of bicyclic lactam derivatives as NMDA receptor antagonists M Espadinha, J Dourado, R Lajarin‐Cuesta, C Herrera‐Arozamena, ... ChemMedChem 12 (7), 537-545, 2017 | 8 | 2017 |
| Optical control of muscular nicotinic channels with azocuroniums, photoswitchable azobenzenes bearing two N-methyl-N-carbocyclic quaternary ammonium groups C Herrera-Arozamena, M Estrada-Valencia, O Martí-Marí, C Pérez, ... European Journal of Medicinal Chemistry 200, 112403, 2020 | 7 | 2020 |
| Identification of tetracyclic lactams as NMDA receptor antagonists with potential application in neurological disorders M Espadinha, L Viejo, RMRM Lopes, C Herrera-Arozamena, E Molins, ... European Journal of Medicinal Chemistry 194, 112242, 2020 | 2 | 2020 |
| Caracterización farmacológica de derivados de melatonina y resveratrol para el potencial tratamiento de la enfermedad de Alzheimer E Sastre-López, C Fernández-Mendivil, JF Franco-Gonzalez, ... | | 2019 |
| Melatonin-and resveratrol-based multitarget-directed agents for Alzheimer's disease and photoswitchable muscular nicotinic receptor ligands C Herrera Arozamena Universidad Complutense de Madrid, 2019 | | 2019 |
| New neurogenic inducers with combined activities in key targets related to Alzheimer¿ s disease C Herrera-Arozamena, M Estrada-Valencia, C Pérez, D Viña, P Michalska, ... | | 2019 |
| Surface plasmon resonance for the discovery of new non-electrophilic inhibitors of KEAP1-NRF2 protein-protein interaction M Estrada-Valencia, C Herrera-Arozamena, L Lagartera, A Cuadrado, ... | | 2019 |
| Structure-Activity Relationship of Potent Photo-Switchable Neuromuscular Inhibitors C Herrera-Arozamena, MH Estrada-Valencia, CA Villalba-Galea, ... Biophysical Journal 116 (3), 395a, 2019 | | 2019 |
| New flavonoid–N, N-dibenzyl (N-methyl) amine hybrids: Multi-target-directed agents for Alzheimer's disease endowed with neurogenic properties M Estrada, C Herrera-Arozamena, C Pérez, D Viña, JA Morales-García, ... Taylor & Francis, 2019 | | 2019 |
| Bicyclic lactams as potential inhibitors of the NMDA receptor M Espadinha, J Dourado, C Herrera-Arozamena, L Gonçalves, J Lopes, ... MDPI AG, 2018 | | 2018 |
| Functional Characterization of Novel Photo-Switchable Neuromuscular Blockers C Herrera-Arozamena, O Martí-Marí, M Estrada, MD Fuente-Revenga, ... Biophysical Journal 114 (3), 297a, 2018 | | 2018 |
Martín Estrada ValenciaCentre for Cancer Newcastle UniversityVerified email at newcastle.ac.uk
